Answers are grounded in this paper and cite their sources.
Oxaliplatin-induced immune thrombocytopenia is a rare but potentially serious complication of chemotherapy. We present the case of a 55-year-old man with stage 4 pancreatic carcinoma who developed immune thrombocytopenia during the 18
No takes yet. Share an insight, caveat, or question.
Şentürk et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: